Treatment of adults with familial hypercholesterolemia and evidence for treatment: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

TY - JOUR

T1 - Treatment of adults with familial hypercholesterolemia and evidence for treatment

T2 - Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

AU - Robinson, Jennifer G.

AU - Goldberg, Anne C.

N1 - Funding Information: The January 2011 NLA FH recommendations conference was supported by unrestricted grant funding from the following companies: Abbott Laboratories, Aegerion Pharmaceuticals, Daiichi Sankyo, Genzyme, Kaneka Pharma America LLC, and Merck & Co. The National Lipid Association would like to thank each company for its support of this endeavor. In accordance with the National Lipid Association Code for Interactions with Companies, the NLA maintained full control over the planning, content, quality, scientific integrity, implementation, and evaluation of the recommendations conference and this FH recommendations paper. All related activities are free from commercial influence and bias. Funding Information: Dr. Robinson's institution has received research grants from Abbott Laboratories, Bristol-Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Hoffman LaRoche, Merck & Co., Merck Schering Plough, and Spirocor. Funding Information: Dr. Goldberg has received honoraria related to consulting from Roche/Genentech, ISIS-Genzyme and Merck & Co. Dr. Goldberg has received research grants from Amarin, Abbott Laboratories, GlaxoSmithKline, ISIS-Genzyme Corporation, Merck & Co., Novartis, and Regeneron.

PY - 2011/6

Y1 - 2011/6

UR - http://www.scopus.com/inward/record.url?scp=79956288028&partnerID=8YFLogxK

U2 - 10.1016/j.jacl.2011.03.451

DO - 10.1016/j.jacl.2011.03.451

M3 - Article

C2 - 21600526

AN - SCOPUS:79956288028

VL - 5

SP - S18-S29

JO - Journal of Clinical Lipidology

JF - Journal of Clinical Lipidology

SN - 1933-2874

IS - 3 SUPPL.

ER -